Related Experiment Video
Updated: Feb 8, 2026

Guidelines and Experience Using Imaging Biomarker Explorer IBEX for Radiomics
Published on: January 8, 2018
Noninvasive renal mass diagnostic models based on radiomic features and clinical data: a multi-center study
Aiming Xu1, Yufan Luo2, Jiajun Xing1
1Department of Urology, The First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
Objectives:
About 20% of renal masses are proved to be benign after surgery. We aimed to develop a strategy based on radiomics to differentially diagnose renal masses.
Methods:
In this retrospective study, 726 renal masses (54 benign and 672 malignant) were collected from two hospitals in China and two public databases. Two diagnostic models, kidney mass diagnosis model (KMDM) and kidney cancer subtypes diagnosis model (KCSDM), were developed for differential diagnosis of renal cell carcinoma and their subtypes. Each model was divided into three units (radiomics model, clinical model, and integrated model) and evaluated in the training set and two independent validation sets.
Methods:
In this retrospective study, 726 renal masses (54 benign and 672 malignant) were collected from two hospitals in China and two public databases. Two diagnostic models, kidney mass diagnosis model (KMDM) and kidney cancer subtypes diagnosis model (KCSDM), were developed for differential diagnosis of renal cell carcinoma and their subtypes. Each model was divided into three units (radiomics model, clinical model, and integrated model) and evaluated in the training set and two independent validation sets.
Results:
A total of 39 radiomic variables were used for the KMDM, and 78 variables for the KCSDM. The radiomics model performed better than the clinical model in both KMDM and KCSDM. The integrated model of KMDM showed the best performance (AUC of 0.937 in training set, 0.942 in both two validation sets), when compared to the other two models and two experts. A cutoff value of risk of malignant index (RMI=1.661) was designated to distinguish the benign and malignant renal masses with a sensitivity of 0.929 and a specificity of 0.833 in validation sets. Similar results were found in the integrated model of KCSDM.
Conclusion:
The integrated model can noninvasively distinguish benign from malignant renal masses and renal cell carcinoma subtypes with satisfactory sensitivity and specificity.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

